These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

78 related articles for article (PubMed ID: 2471228)

  • 21. [The involvement of 5-HT1a serotonin receptors in the pathophysiology and pharmacotherapy of schizophrenia].
    Maćkowiak M; Czyrak A; Wedzony K
    Psychiatr Pol; 2000; 34(4):607-21. PubMed ID: 11059260
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Neuroleptic treatment of patients with schizophrenia. Mechanisms of action and clinical significance.
    Wiesel FA
    Br J Psychiatry Suppl; 1994 Apr; (23):65-70. PubMed ID: 7913610
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effects of acute and subchronic administration of typical and atypical antipsychotic drugs on the neurotensin system of the rat brain.
    Kinkead B; Shahid S; Owens MJ; Nemeroff CB
    J Pharmacol Exp Ther; 2000 Oct; 295(1):67-73. PubMed ID: 10991962
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Substance P and neuropsychiatric disorders: an overview.
    Malek-Ahmadi P
    Neurosci Biobehav Rev; 1992; 16(3):365-9. PubMed ID: 1382254
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Cognitive neuroscience and schizophrenia: translational research in need of a translator.
    Cohen JD; Insel TR
    Biol Psychiatry; 2008 Jul; 64(1):2-3. PubMed ID: 18549873
    [No Abstract]   [Full Text] [Related]  

  • 26. Brain-derived neurotrophic factor in schizophrenia and its relation with dopamine.
    Guillin O; Demily C; Thibaut F
    Int Rev Neurobiol; 2007; 78():377-95. PubMed ID: 17349867
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Defining the brain circuits involved in psychiatric disorders: IMI-NEWMEDS.
    Artigas F; Schenker E; Celada P; Spedding M; Lladó-Pelfort L; Jurado N; Núñez M; Santana N; Troyano-Rodriguez E; Riga MS; van den Munkhof H; Castañé A; Shaban H; Jay TM; Tripathi A; Godsil BP; Sebban C; Mariani J; Faure P; Takkilah S; Hughes ZA; Siok CJ; Hajos M; Wicke K; Gass N; Weber-Fahr W; Sartorius A; Becker R; Didriksen M; Bastlund JF; Tricklebank M; Risterucci C; Meyer-Lindenberg A; Schwarz AJ
    Nat Rev Drug Discov; 2017 Jan; 16(1):1-2. PubMed ID: 27811930
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [A model of regulation of several shifts in the circulatory system and prospects for its use in schizophrenic patients].
    Kudriashev VE; Rabshteĭn VA; Labutskiĭ AK; Kudriasheva OV
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1977; 77(9):1395-9. PubMed ID: 919969
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Cholinergic involvement in mental disorders.
    Davis KL; Berger PA; Hollister LE; Barchas JD
    Life Sci; 1978 Jun; 22(21):1865-71. PubMed ID: 27686
    [No Abstract]   [Full Text] [Related]  

  • 30. Molecular profiling of antipsychotic drug function: convergent mechanisms in the pathology and treatment of psychiatric disorders.
    Thomas EA
    Mol Neurobiol; 2006 Oct; 34(2):109-28. PubMed ID: 17220533
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The biological roots of mental illness: their ramifications through cerebral metabolism, synaptic activity, genetics, and the environment.
    Kety SS
    Harvey Lect; 1978; 71():1-22. PubMed ID: 711440
    [No Abstract]   [Full Text] [Related]  

  • 32. [Investigation of depth perspective in psychiatric patients by polarization stereometry (author's transl)].
    Rennert H; Wäldrich B
    Nervenarzt; 1979 Nov; 50(11):738-42. PubMed ID: 537663
    [No Abstract]   [Full Text] [Related]  

  • 33. [A role for the cytoskeleton in mental diseases?].
    Andrieux A; Job D
    Med Sci (Paris); 2003 Feb; 19(2):135-7. PubMed ID: 12836603
    [No Abstract]   [Full Text] [Related]  

  • 34. Prolactin and psychiatry.
    Meltzer HY
    Am J Psychiatry; 1981 Sep; 138(9):1203-6. PubMed ID: 6115585
    [No Abstract]   [Full Text] [Related]  

  • 35. Neural syntax in mental disorders.
    Watson BO; Buzsáki G
    Biol Psychiatry; 2015 Jun; 77(12):998-1000. PubMed ID: 26005113
    [No Abstract]   [Full Text] [Related]  

  • 36. [Psychiatric problems with special reference to physical movement].
    Tatetsu S
    Nihon Ishikai Zasshi; 1967 Dec; 58(11):1279-83. PubMed ID: 5627267
    [No Abstract]   [Full Text] [Related]  

  • 37. Brain opiates in mental illness.
    Marx JL
    Science; 1981 Nov; 214(4524):1013-15. PubMed ID: 7302574
    [No Abstract]   [Full Text] [Related]  

  • 38. Increased bowel permeability in psychiatric disorder: relevance of thromboxane.
    Backon J
    Med Hypotheses; 1991 Nov; 36(3):225-7. PubMed ID: 1787816
    [No Abstract]   [Full Text] [Related]  

  • 39. [What is characteristic of schizophrenia in a schizophrenic].
    KAHN E
    Monatsschr Psychiatr Neurol; 1952; 124(4-6):328-33. PubMed ID: 13025335
    [No Abstract]   [Full Text] [Related]  

  • 40. Commentary: Anatomical constitution of sense organs as a marker of mental disorders.
    Schwitzer T; Schwan R; Bernardin F; Jeantet C; Angioi-Duprez K; Laprevote V
    Front Behav Neurosci; 2016; 10():56. PubMed ID: 27047357
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.